# A Young Hispanic with c.1646G>A Mutation Exhibits Severe Cystic Fibrosis Lung Disease: Is Ivacaftor an Option for Therapy?

## Metadata
**Authors:** Sunitha Yarlagadda, Weiqiang Zhang, Himabindu Penmatsa, Aixia Ren, Kavisha Arora, Anjaparavanda P Naren, Fatima Anmol I Khan, Catherine A Donnellan, Saumini Srinivasan, Dennis C Stokes, John C Kappes
**Journal:** American Journal of Respiratory and Critical Care Medicine
**Date:** 2012 Oct 1
**DOI:** [10.1164/ajrccm.186.7.694](https://doi.org/10.1164/ajrccm.186.7.694)
**PMID:** 23027855
**PMCID:** PMC3480516
**URL:** https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480516/
**PDF:** [https://pmc.ncbi.nlm.nih.gov/articles/PMC3480516/pdf/AJRCCM1867694.pdf](https://pmc.ncbi.nlm.nih.gov/articles/PMC3480516/pdf/AJRCCM1867694.pdf)

## Supplementary Material

## Footnotes

## Associated Data

*This section collects any data citations, data availability statements, or supplementary materials included in this article.*

### Supplementary Materials

### Supplementary Materials

## References

1. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, O'Riordan CR, Smith AE. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 1990;63:827–834  [DOI](https://doi.org/10.1016/0092-8674(90)90148-8) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/1699669/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cell&title=Defective%20intracellular%20transport%20and%20processing%20of%20CFTR%20is%20the%20molecular%20basis%20of%20most%20cystic%20fibrosis&author=SH%20Cheng&author=RJ%20Gregory&author=J%20Marshall&author=S%20Paul&author=DW%20Souza&volume=63&publication_year=1990&pages=827-834&pmid=1699669&doi=10.1016/0092-8674(90)90148-8&)

2. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993;73:1251–1254  [DOI](https://doi.org/10.1016/0092-8674(93)90353-r) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/7686820/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cell&title=Molecular%20mechanisms%20of%20CFTR%20chloride%20channel%20dysfunction%20in%20cystic%20fibrosis&author=MJ%20Welsh&author=AE%20Smith&volume=73&publication_year=1993&pages=1251-1254&pmid=7686820&doi=10.1016/0092-8674(93)90353-r&)

3. Penmatsa H, Frederick CA, Nekkalapu S, Conoley VG, Zhang W, Li C, Kappes J, Stokes DC, Naren AP. Clinical and molecular characterization of S1118F-CFTR. Pediatr Pulmonol 2009;44:1003–1009  [DOI](https://doi.org/10.1002/ppul.21092) | [PMC free article](/articles/PMC2821577/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/19774621/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Pediatr%20Pulmonol&title=Clinical%20and%20molecular%20characterization%20of%20S1118F-CFTR&author=H%20Penmatsa&author=CA%20Frederick&author=S%20Nekkalapu&author=VG%20Conoley&author=W%20Zhang&volume=44&publication_year=2009&pages=1003-1009&pmid=19774621&doi=10.1002/ppul.21092&)

4. Rohlfs EM, Zhou Z, Heim RA, Nagan N, Rosenblum LS, Flynn K, Scholl T, Akmaev VR, Sirko-Osadsa DA, Allitto BA, et al. Cystic fibrosis carrier testing in an ethnically diverse US population. Clin Chem 2011;57:841–848  [DOI](https://doi.org/10.1373/clinchem.2010.159285) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/21474639/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Clin%20Chem&title=Cystic%20fibrosis%20carrier%20testing%20in%20an%20ethnically%20diverse%20US%20population&author=EM%20Rohlfs&author=Z%20Zhou&author=RA%20Heim&author=N%20Nagan&author=LS%20Rosenblum&volume=57&publication_year=2011&pages=841-848&pmid=21474639&doi=10.1373/clinchem.2010.159285&)

5. Sugarman EA, Rohlfs EM, Silverman LM, Allitto BA. CFTR mutation distribution among Hispanic US and African American individuals: evaluation in cystic fibrosis patient and carrier screening populations. Genet Med 2004;6:392–399  [DOI](https://doi.org/10.1097/01.gim.0000139503.22088.66) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/15371903/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Genet%20Med&title=CFTR%20mutation%20distribution%20among%20Hispanic%20US%20and%20African%20American%20individuals:%20evaluation%20in%20cystic%20fibrosis%20patient%20and%20carrier%20screening%20populations&author=EA%20Sugarman&author=EM%20Rohlfs&author=LM%20Silverman&author=BA%20Allitto&volume=6&publication_year=2004&pages=392-399&pmid=15371903&doi=10.1097/01.gim.0000139503.22088.66&)

6. Curtis A, Richardson RJ, Boohene J, Jackson A, Nelson R, Bhattacharya SS. Absence of cystic fibrosis mutations in a large Asian population sample and occurrence of a homozygous S549N mutation in an inbred Pakistani family. J Med Genet 1993;30:164–166  [DOI](https://doi.org/10.1136/jmg.30.2.164) | [PMC free article](/articles/PMC1016278/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/7680378/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J%20Med%20Genet&title=Absence%20of%20cystic%20fibrosis%20mutations%20in%20a%20large%20Asian%20population%20sample%20and%20occurrence%20of%20a%20homozygous%20S549N%20mutation%20in%20an%20inbred%20Pakistani%20family&author=A%20Curtis&author=RJ%20Richardson&author=J%20Boohene&author=A%20Jackson&author=R%20Nelson&volume=30&publication_year=1993&pages=164-166&pmid=7680378&doi=10.1136/jmg.30.2.164&)

7. Van Goor F, Hadida S, Grootenhuis PD, Burton B, Cao D, Neuberger T, Turnbull A, Singh A, Joubran J, Hazlewood A, et al. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc Natl Acad Sci U S A 2009;106:18825–18830  [DOI](https://doi.org/10.1073/pnas.0904709106) | [PMC free article](/articles/PMC2773991/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/19846789/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&title=Rescue%20of%20CF%20airway%20epithelial%20cell%20function%20in%20vitro%20by%20a%20CFTR%20potentiator,%20VX-770&author=F%20Van%20Goor&author=S%20Hadida&author=PD%20Grootenhuis&author=B%20Burton&author=D%20Cao&volume=106&publication_year=2009&pages=18825-18830&pmid=19846789&doi=10.1073/pnas.0904709106&)

8. Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, Dřevínek P, Griese M, McKone EF, Wainwright CE, Konstan MW, et al. ; VX08–770–102 Study Group. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 2011;365:1663–1672  [DOI](https://doi.org/10.1056/NEJMoa1105185) | [PMC free article](/articles/PMC3230303/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/22047557/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&title=VX08%E2%80%93770%E2%80%93102%20Study%20Group.%20A%20CFTR%20potentiator%20in%20patients%20with%20cystic%20fibrosis%20and%20the%20G551D%20mutation&author=BW%20Ramsey&author=J%20Davies&author=NG%20McElvaney&author=E%20Tullis&author=SC%20Bell&volume=365&publication_year=2011&pages=1663-1672&pmid=22047557&doi=10.1056/NEJMoa1105185&)

9. Yu H, Burton B, Huang CJ, Worley J, Cao D, Johnson JP, Jr, Urrutia A, Joubran J, Seepersaud S, Sussky K, et al. Ivacaftor potentiation of multiple CFTR channels with gating mutations. J Cyst Fibros 2012;11:237–245  [DOI](https://doi.org/10.1016/j.jcf.2011.12.005) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/22293084/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J%20Cyst%20Fibros&title=Ivacaftor%20potentiation%20of%20multiple%20CFTR%20channels%20with%20gating%20mutations&author=H%20Yu&author=B%20Burton&author=CJ%20Huang&author=J%20Worley&author=D%20Cao&volume=11&publication_year=2012&pages=237-245&pmid=22293084&doi=10.1016/j.jcf.2011.12.005&)

10. Cystic Fibrosis Foundation. FDA Approves Kalydeco (VX-770)—first drug that targets the underlying cause of cystic fibrosis [accessed 2012 January 31]. Available from: http://www.cff.org/aboutCFFoundation/NewsEvents/1-31-FDA-Approves-Kalydeco.cfm.  [http://www.cff.org/aboutCFFoundation/NewsEvents/1-31-FDA-Approves-Kalydeco.cfm](http://www.cff.org/aboutCFFoundation/NewsEvents/1-31-FDA-Approves-Kalydeco.cfm)

11. Van Goor F, Hadida S, Grootenhuis PD, Burton B, Stack JH, Straley KS, Decker CJ, Miller M, McCartney J, Olson ER, et al. Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc Natl Acad Sci U S A 2011;108:18843–18848  [DOI](https://doi.org/10.1073/pnas.1105787108) | [PMC free article](/articles/PMC3219147/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/21976485/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&title=Correction%20of%20the%20F508del-CFTR%20protein%20processing%20defect%20in%20vitro%20by%20the%20investigational%20drug%20VX-809&author=F%20Van%20Goor&author=S%20Hadida&author=PD%20Grootenhuis&author=B%20Burton&author=JH%20Stack&volume=108&publication_year=2011&pages=18843-18848&pmid=21976485&doi=10.1073/pnas.1105787108&)

12. Li C, Krishnamurthy PC, Penmatsa H, Marrs KL, Wang XQ, Zaccolo M, Jalink K, Li M, Nelson DJ, Schuetz JD, Naren AP. Spatiotemporal coupling of cAMP transporter to CFTR chloride channel function in the gut epithelia. Cell 2007;13:940–951  [DOI](https://doi.org/10.1016/j.cell.2007.09.037) | [PMC free article](/articles/PMC2174212/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/18045536/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cell&title=Spatiotemporal%20coupling%20of%20cAMP%20transporter%20to%20CFTR%20chloride%20channel%20function%20in%20the%20gut%20epithelia&author=C%20Li&author=PC%20Krishnamurthy&author=H%20Penmatsa&author=KL%20Marrs&author=XQ%20Wang&volume=13&publication_year=2007&pages=940-951&pmid=18045536&doi=10.1016/j.cell.2007.09.037&)
